Published in Eur J Cardiothorac Surg on August 25, 2012
Effective Management of Calcific Aortic Stenosis in the Elderly (RAC) | NCT03343314
Aortic biological valve prosthesis in patients younger than 65 years of age: transition to a flexible age limit? Interact Cardiovasc Thorac Surg (2013) 1.92
Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?: Insights From the STS/ACC TVT Registry. J Am Coll Cardiol (2016) 1.42
The role of exercise echocardiography in the management of mitral valve disease. Neth Heart J (2013) 1.42
Baseline MDCT findings after prosthetic heart valve implantation provide important complementary information to echocardiography for follow-up purposes. Eur Radiol (2015) 1.39
Flexible band versus rigid ring annuloplasty for functional tricuspid regurgitation: two different patterns of right heart reverse remodelling. Interact Cardiovasc Thorac Surg (2016) 1.31
Implantation of personalized, biocompatible mitral annuloplasty rings: feasibility study in an animal model. Interact Cardiovasc Thorac Surg (2013) 1.09
Quality of life among patients with severe aortic stenosis. Neth Heart J (2013) 1.08
The effect of aortic valve replacement on quality of life in symptomatic patients with severe aortic stenosis. Neth Heart J (2013) 1.02
Cardiologist and cardiac surgeon view on decision-making in prosthetic aortic valve selection: does profession matter? Neth Heart J (2014) 1.01
What the cardiothoracic surgeon wants to know from the radiologist: from X-ray reporting to imaging consultancy and Heart Team membership. Pediatr Radiol (2015) 0.95
Single-centre experience of mitral valve surgery via right lateral mini-thoracotomy in octogenarians. Interact Cardiovasc Thorac Surg (2015) 0.91
Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol (2014) 0.88
Surgical treatment of aortic valve disease. Nat Rev Cardiol (2013) 0.87
Beyond adding years to life: health-related quality-of-life and functional outcomes in patients with severe aortic valve stenosis at high surgical risk undergoing transcatheter aortic valve replacement. Curr Cardiol Rev (2013) 0.87
Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis. Clin Res Cardiol (2015) 0.86
Comparable long-term results for porcine and pericardial prostheses after isolated aortic valve replacement. Eur J Cardiothorac Surg (2014) 0.84
Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice. Dtsch Arztebl Int (2014) 0.83
Hybrid Imaging During Transcatheter Structural Heart Interventions. Curr Cardiovasc Imaging Rep (2015) 0.82
Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation. Arq Bras Cardiol (2013) 0.82
Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications. Cardiovasc Diagn Ther (2013) 0.81
Minimal access aortic valve replacement via limited skin incision and complete median sternotomy. J Thorac Dis (2013) 0.80
Left atrial appendage exclusion-Where do we stand? J Thorac Dis (2014) 0.80
Current topics on bicuspid aortic valve: clinical aspects and surgical management. Ann Thorac Cardiovasc Surg (2015) 0.80
Parallel improvement of left ventricular geometry and filling pressure after transcatheter aortic valve implantation in high risk aortic stenosis: comparison with major prosthetic surgery by standard echo Doppler evaluation. Cardiovasc Ultrasound (2013) 0.80
Functional mitral regurgitation: a 30-year unresolved surgical journey from valve replacement to complex valve repairs. Heart Fail Rev (2014) 0.79
Is chordal-preserving mitral valve replacement superior to valve repair in appropriately selected patients? J Thorac Dis (2016) 0.79
Symptomatic severe aortic stenosis in the TAVI era: heart team assessment for all. Neth Heart J (2012) 0.78
Left ventricular regional function and maximal exercise capacity in aortic stenosis. Eur Heart J Cardiovasc Imaging (2015) 0.78
Molecular mechanisms in male determination and germ cell differentiation. Cell Mol Life Sci (2004) 0.78
Multicenter evaluation of high-risk mitral valve operations: implications for novel transcatheter valve therapies. Ann Thorac Surg (2014) 0.78
Contemporary outcomes after surgical aortic valve replacement with bioprostheses and allografts: a systematic review and meta-analysis. Eur J Cardiothorac Surg (2016) 0.78
Right coronary cusp perforation after mitral valve replacement. Interact Cardiovasc Thorac Surg (2012) 0.78
Rheumatic heart disease screening: Current concepts and challenges. Ann Pediatr Cardiol (2017) 0.78
Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip). Clin Res Cardiol (2016) 0.78
Conventional versus rapid-deployment aortic valve replacement: a single-centre comparison between the Edwards Magna valve and its rapid-deployment successor. Interact Cardiovasc Thorac Surg (2016) 0.77
Computed tomography for planning and postoperative imaging of transvenous mitral annuloplasty: first experience in an animal model. Int J Cardiovasc Imaging (2014) 0.77
Sleep in octogenarians during the postoperative phase after transcatheter or surgical aortic valve replacement. Eur J Cardiovasc Nurs (2015) 0.77
Mitral transcatheter technologies. Rambam Maimonides Med J (2013) 0.77
Results of mitral valve repair with an adjustable annuloplasty ring 2 years after implantation. Heart Vessels (2016) 0.77
Subclinical left ventricular systolic impairment in steady state young adult patients with sickle-cell anemia. Int J Cardiovasc Imaging (2014) 0.77
Mitral valve replacement after failed MitraClip™ therapy: report of two cases. J Artif Organs (2014) 0.77
A Case Based Approach to Clinical Genetics of Thoracic Aortic Aneurysm/Dissection. Biomed Res Int (2016) 0.76
Inflammation Drives Retraction, Stiffening, and Nodule Formation via Cytoskeletal Machinery in a Three-Dimensional Culture Model of Aortic Stenosis. Am J Pathol (2016) 0.76
Transcatheter aortic valve implantation. F1000Prime Rep (2014) 0.76
Aortic valve area assessed with 320-detector computed tomography: comparison with transthoracic echocardiography. Int J Cardiovasc Imaging (2013) 0.76
Tricuspid valve surgery. HSR Proc Intensive Care Cardiovasc Anesth (2012) 0.75
Single-centre experience with mitral valve repair in asymptomatic patients with severe mitral valve regurgitation. Interact Cardiovasc Thorac Surg (2013) 0.75
Rebuttal to: choice of prosthetic valve in a developing country. Heart Asia (2016) 0.75
Acute obstruction of a mechanical aortic valve in a young woman: case report and review of the literature. Echo Res Pract (2014) 0.75
Lancisi sign: giant C-V waves of tricuspid regurgitation. Intern Emerg Med (2016) 0.75
Metastatic carcinoid tumor presenting as right sided heart failure. Int J Endocrinol Metab (2013) 0.75
Aortic valve replacement in young and middle-aged adults: looking beyond the tree that hides the forest. Ann Transl Med (2017) 0.75
Pathophysiology and management of multivalvular disease. Nat Rev Cardiol (2016) 0.75
Myocardial strain and symptom severity in severe aortic stenosis: insights from cardiovascular magnetic resonance. Quant Imaging Med Surg (2017) 0.75
Multiple Strokes Secondary to an Early Thrombosis of Aortic Bioprosthesis on Aspirin Therapy. J Cardiovasc Echogr (2017) 0.75
Improvement in left ventricular function assessed by tissue Doppler imaging after aortic valve replacement for severe aortic stenosis. Singapore Med J (2015) 0.75
Mid- to long-term outcome comparison of the Medtronic Hancock II and bi-leaflet mechanical aortic valve replacement in patients younger than 60 years of age: a propensity-matched analysis. Interact Cardiovasc Thorac Surg (2015) 0.75
Cardiovascular magnetic resonance assessment of the aortic valve stenosis: an in vivo and ex vivo study. BMC Med Imaging (2015) 0.75
Clinical outcomes of conventional surgery versus MitraClip® therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience. BMC Cardiovasc Disord (2017) 0.75
The importance of contrast volume/glomerular filtration rate ratio in contrast-induced nephropathy patients after transcatheter aortic valve implantation. Cardiorenal Med (2014) 0.75
Left ventricle-mitral valve ring size mismatch: understanding the limitations of mitral valve repair for ischemic mitral regurgitation. Ann Transl Med (2017) 0.75
eComment. Beyond the tricuspid annuloplasty techniques. Interact Cardiovasc Thorac Surg (2013) 0.75
Feasibility of a new method using two-dimensional transesophageal echocardiography for aortic annular sizing in patients undergoing transcatheter aortic valve implantation; a case-control study. BMC Cardiovasc Disord (2015) 0.75
Gender-specific differences in outcome of ascending aortic aneurysm surgery. PLoS One (2015) 0.75
A mechanical heart valve is the best choice. Heart Asia (2016) 0.75
New Insights in the Diagnosis and Treatment of Heart Failure. Biomed Res Int (2015) 0.75
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study. Drugs R D (2016) 0.75
Minimally invasive approach for redo mitral valve surgery. J Thorac Dis (2013) 0.75
The effects of Ramadan fasting on patients with prosthetic heart valve taking warfarin for anticoagulation. J Saudi Heart Assoc (2016) 0.75
Successful mitral valve repair in infective endocarditis. Case report and review of the data in the literature. Maedica (Buchar) (2012) 0.75
Minimally invasive approach to calcified aortic valve replacement: Anaesthetic considerations. Indian J Anaesth (2015) 0.75
International Expert Consensus on Sutureless and Rapid Deployment Valves in Aortic Valve Replacement Using Minimally Invasive Approaches. Innovations (Phila) (2016) 0.75
Catheter-based or surgical repair of the highest risk secondary mitral regurgitation patients. Ann Cardiothorac Surg (2015) 0.75
New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3). Aorta (Stamford) (2013) 0.75
Aortopathy associated with congenital heart disease: A current literature review. Ann Pediatr Cardiol (2015) 0.75
Mitral Valve Clip for Treatment of Mitral Regurgitation: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2015) 0.75
Mortality after percutaneous edge-to-edge mitral valve repair: a contemporary review. Cardiovasc Diagn Ther (2016) 0.75
eComment. Cardiac bioprostheses: new focuses for new times. Interact Cardiovasc Thorac Surg (2013) 0.75
Cardiac surgery for infective endocarditis in patients with intravenous drug use. Interact Cardiovasc Thorac Surg (2016) 0.75
Pulmonary capillary wedge pressure and natriuretic peptide levels in patients with sinus rhythm and severe left atrial enlargement following mitral valve surgery: early and late changes. Heart Lung Vessel (2015) 0.75
Biomarkers of Calcific Aortic Valve Disease. Arterioscler Thromb Vasc Biol (2017) 0.75
Should the guidelines for the assessment of the severity of functional mitral regurgitation be redefined? JACC Cardiovasc Imaging (2014) 0.75
Mitral valve repair for moderate ischemic mitral regurgitation. J Thorac Dis (2016) 0.75
Two-dimensional transesophageal echocardiography for aortic annular sizing in patients undergoing transcatheter aortic valve implantation. BMC Cardiovasc Disord (2015) 0.75
Cardiovascular magnetic resonance evaluation of symptomatic severe aortic stenosis: association of circumferential myocardial strain and mortality. J Cardiovasc Magn Reson (2017) 0.75
Quality of life and prosthetic aortic valve selection in non-elderly adult patients. Interact Cardiovasc Thorac Surg (2016) 0.75
Surgical technique: establishing a pre-clinical large animal model to test aortic valve leaflet substitute. J Thorac Dis (2016) 0.75
Transcatheter aortic valve implantation: a revolution in the therapy of elderly and high-risk patients with severe aortic stenosis. J Geriatr Cardiol (2017) 0.75
eComment. The majority of younger patients in the USA chose biological aortic valves. Interact Cardiovasc Thorac Surg (2013) 0.75
Two melodies in concert: mitral and pulmonary valve replacement late in repaired tetralogy of Fallot. J Cardiothorac Surg (2015) 0.75
Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE). BMC Cardiovasc Disord (2017) 0.75
Efficacy and Safety of Transcatheter Aortic Valve Implantation for Bicuspid Aortic Valves: A Systematic Review and Meta-Analysis. Ann Thorac Cardiovasc Surg (2016) 0.75
Assessment of concomitant paroxysmal atrial fibrillation ablation in mitral valve surgery patients based on continuous monitoring: does a different lesion set matter? Interact Cardiovasc Thorac Surg (2013) 0.75
eComment. Role of global longitudinal strain for evaluation of asymptomatic severe aortic stenosis. Interact Cardiovasc Thorac Surg (2013) 0.75
Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral Stenosis. Medicine (Baltimore) (2016) 0.75
Multicentre, propensity-matched study to evaluate long-term impact of implantation technique in isolated aortic valve replacement on mortality and incidence of redo surgery. Interact Cardiovasc Thorac Surg (2016) 0.75
The impact of transcatheter aortic valve implantation on left ventricular performance and wall thickness - single-centre experience. Postepy Kardiol Interwencyjnej (2015) 0.75
Non invasive evaluation of cardiomechanics in patients undergoing MitrClip procedure. Cardiovasc Ultrasound (2013) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr (2009) 14.63
Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J (2008) 12.31
Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med (2014) 11.77
Universal definition of myocardial infarction. Circulation (2007) 11.69
Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
Clinical end points in coronary stent trials: a case for standardized definitions. Circulation (2007) 10.31
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med (2012) 9.22
Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet (2007) 7.61
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J (2003) 6.88
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J (2010) 6.45
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA (2007) 6.25
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79